Gilead shares jumped.

<p>Gilead Sciences shares rose 16% on Thursday after media reports of partial test results of the experimental drug Remdesivir in severe patients with coronavirus. </p>
<p> </p>
<p> </p>
<p> </p>
<p> The STAT medical news website, citing a recorded discussion between doctors participating in the clinical trial, said that most patients taking Gilead's Remdesivir drug in a hospital in Chicago recovered. </p>